Skip to main content

Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV

  • Research Report
  • Chapter
  • First Online:
JIMD Reports, Volume 45

Part of the book series: JIMD Reports ((JIMD,volume 45))

Abstract

Glycogen storage disease type IV (GSD-IV), or Andersen disease, is a rare autosomal recessive disorder that results from the deficiency of glycogen branching enzyme (GBE). This in turn results in accumulation of abnormal glycogen molecules that have longer outer chains and fewer branch points. GSD-IV manifests in a wide spectrum, with variable phenotypes depending on the degree and type of tissues in which this abnormal glycogen accumulates. Typically, GSD-IV presents with rapidly progressive liver cirrhosis and death in early childhood. However, there is a severe congenital neuromuscular variant of GSD-IV that has been reported in the literature, with fewer than 20 patient cases thus far. We report an unusual case of GSD-IV neuromuscular variant in a late preterm female infant who was born to non-consanguineous healthy parents with previously healthy children. Prenatally, our patient was found to have decreased fetal movement and polyhydramnios warranting an early delivery. Postnatally, she had severe hypotonia and respiratory failure, with no hepatic or cardiac involvement. Extensive metabolic and neurological workup revealed no abnormalities. However, molecular analysis by whole-exome sequencing revealed two pathogenic variants in the GBE1 gene. Our patient was thus a compound heterozygote of the two pathogenic variants: one of these was inherited from the mother [p.L490WfsX5 (c.1468delC)], and the other pathogenic variant was a de novo change [p.E449X (c.1245G>T)]. As expected in GSD-IV, diffuse intracytoplasmic periodic acid-Schiff-positive, diastase-resistant inclusions were found in the cardiac myocytes, hepatocytes, and skeletal muscle fibers of our patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alegria A, Martins E, Dias M, Cunha A, Cardoso ML, Maire I (1999) Glycogen storage disease type IV presenting as hydrops fetalis. J Inherit Metab Dis 22:330–332

    Article  CAS  Google Scholar 

  • Andersen DH (1956) Familial cirrhosis of the liver with storage of abnormal glycogen. Lab Invest 5:11–20

    CAS  PubMed  Google Scholar 

  • Assereto S, van Diggelen OP, Diogo L et al (2007) Null mutations and lethal congenital form of glycogen storage disease type IV. Biochem Biophys Res Commun 361:445–450

    Article  CAS  Google Scholar 

  • Bao Y, Kishnani P, Wu JY, Chen YT (1996) Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest 97:941–948

    Article  CAS  Google Scholar 

  • Bruno C, Servidei S, Shanske S et al (1993) Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol 33:88–93

    Article  CAS  Google Scholar 

  • Bruno C, van Diggelen OP, Cassandrini D et al (2004) Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV). Neurology 63:1053–1058

    Article  CAS  Google Scholar 

  • Bruno C, Cassandrini D, Assereto S, Akman HO, Minetti C, Di Mauro S (2007) Neuromuscular forms of glycogen branching enzyme deficiency. Acta Myol 26:75–78

    CAS  PubMed  PubMed Central  Google Scholar 

  • Burrow TA, Hopkin RJ, Bove KE et al (2006) Non-lethal congenital hypotonia due to glycogen storage disease type IV. Am J Med Genet A 140:878–882

    Article  Google Scholar 

  • Fernandez C, Halbert C, De Paula AM et al (2010) Non-lethal neonatal neuromuscular variant of glycogenosis type IV with novel GBE1 mutations. Muscle Nerve 41:269–271

    CAS  PubMed  Google Scholar 

  • Lamperti C, Salani S, Lucchiari S et al (2009) Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene. J Inherit Metab Dis 32(Suppl 1):S161–S168

    Article  Google Scholar 

  • McConkie-Rosell A, Wilson C, Piccoli DA et al (1996) Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis 19:51–58

    Article  CAS  Google Scholar 

  • McMaster KR, Powers JM, Hennigar GR Jr, Wohltmann HJ, Farr GH Jr (1979) Nervous system involvement in type IV glycogenosis. Arch Pathol Lab Med 103:105–111

    CAS  PubMed  Google Scholar 

  • Reusche E, Aksu F, Goebel HH, Shin YS, Yokota T, Reichmann H (1992) A mild juvenile variant of type IV glycogenosis. Brain Dev 14:36–43

    Article  CAS  Google Scholar 

  • Tang TT, Segura AD, Chen YT et al (1994) Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis. Acta Neuropathol 87:531–536

    Article  CAS  Google Scholar 

  • Tay SK, Akman HO, Chung WK et al (2004) Fatal infantile neuromuscular presentation of glycogen storage disease type IV. Neuromuscul Disord 14:253–260

    Article  Google Scholar 

  • Thon VJ, Khalil M, Cannon JF (1993) Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast. J Biol Chem 268:7509–7513

    CAS  PubMed  Google Scholar 

  • Zellweger H, Mueller S, Ionasescu V, Schochet SS, McCormick WF (1972) Glycogenosis. IV. A new cause of infantile hypotonia. J Pediatr 80:842–844

    Article  CAS  Google Scholar 

Download references

Acknowledgment

We thank Kathy Kyler for editorial support throughout writing process. We thank Drs. Henry Tran and Kar-Ming Fung for their assistant in sampling and examining the thigh muscular tissue.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tavleen Sandhu .

Editor information

Editors and Affiliations

Additional information

Communicated by: Terry G.J. Derks, MD, PhD

Compliance with Ethics Guidelines

Compliance with Ethics Guidelines

Tavleen Sandhu, Michelle Polan, Zhongxin Yu, Rufei Lu, and Abhishek Makkar declare that they have no conflicts of interest.

Tavleen Sandhu and Abhishek Makkar were the members of the primary medical team for the patient and were involved in planning, conduct, and reporting of the case. Michelle Polan, Zhongxin Yu, and Rufei Lu were part of the consultancy team and were involved in reporting of the case. Abhishek Makkar is the guarantor for this manuscript.

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Society for the Study of Inborn Errors of Metabolism (SSIEM)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sandhu, T., Polan, M., Yu, Z., Lu, R., Makkar, A. (2018). Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 45. JIMD Reports, vol 45. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2018_142

Download citation

  • DOI: https://doi.org/10.1007/8904_2018_142

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-58646-4

  • Online ISBN: 978-3-662-58647-1

  • eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Publish with us

Policies and ethics